ZN
Zentalis Pharmaceuticals, Inc.
ZNTL · NASDAQ
$3.08 -3.14% (-$0.10)
1M -19.37%
Market Cap $219.3M
P/E Ratio -
Div. Yield -
ROE 87.95%
Bulios Fair Price
$2.47
19.8% downside
Trenutna cena
$3.08
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ZNTL trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
99 /100
Cheap P/B 1.53x
P/FCF N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 20.72%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROA 81.22%
ROIC 105.66%
Debt
100 /100
Low Current ratio 4.82x
Debt/Equity 0.26x
Net debt/EBITDA N/A
Stability
35 /100
Moderate EPS volatility 24.08%
Profitable years 0
Beta 1.86x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ZNTL
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Julia Marie Eastland
Employees
106
Headquarters
San Diego
Prihajajoči dogodki
10 NOV.
Earnings
Upcoming earnings report